A protumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma. - Tan X; Shi L; Banerjee P; Liu X; Guo HF; Yu J; Bota-Rabassedas N; Rodriguez BL; Gibbons DL; Russell WK; Creighton CJ; Kurie JM (The Journal of clinical investigation, 2021)